REGENXBIO Inc (NASDAQ: RGNX) stock closed at $14.44 on 1/8/24 after a major decline of -12.2%. Moreover, trading volume in this decline was exceptionally high at 310% of normal. The stock has performed in line with the market over the last nine months and has declined -22.1% during the last week.
Current PriceTarget Research Rating
RGNX is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
REGENXBIO has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. REGENXBIO has a neutral Power Rating of 46 but a poor Appreciation Score of 25, and the Negative Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment